The results showed that among all variables, tumour size, lymph node metastasis, TNM stages III and IV, high miR-451a expression and high KDM7A expression had significant impacts on cetuximab resistance (Fig. 6g). The gene discussed is KDM7A; the disease is metastatic malignant neoplasm in the lymph nodes.